Pardoprunox
Pardoprunox Uses, Dosage, Side Effects, Food Interaction and all others data.
Pardoprunox has been used in trials studying the treatment of Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease. Pardoprunox is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties.
| Trade Name | Pardoprunox |
| Generic | Pardoprunox |
| Pardoprunox Other Names | Pardoprunox |
| Type | |
| Formula | C12H15N3O2 |
| Weight | Average: 233.271 Monoisotopic: 233.116426735 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How Pardoprunox works
Pardoprunox binds to dopamine D(2), D(3), and D(4) receptors and 5-HT(1) (A) receptors and is a partial agonist at dopamine D(2) and D(3) receptors and a full agonist at serotonin 5-HT(1) (A) receptors. Pardoprunox combines high potency partial agonism at dopamine D(2) and D(3) receptors with full efficacy low potency serotonin 5-HT(1) (A) receptor agonism and is worthy of profiling in in vivo models of Parkinson's disease.
Innovators Monograph
You find simplified version here Pardoprunox
